Fifth Third Bancorp
KURA icon

Fifth Third Bancorp’s Kura Oncology KURA Stock Holding History

Fifth Third Bancorp’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.5K Sell
1,415
-728
-34% -$6.87K ﹤0.01% 3620
2026
Q1 		$17.4K Buy
+2,143
New +$18.4K ﹤0.01% 3534

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Fifth Third Bancorp's KURA Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Kura Oncology (KURA) stake by 34% in Q2 2026, selling an estimated $6.87K and leaving 1,415 shares worth $15.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3620.

Fifth Third Bancorp first reported a position in KURA in Q1 2026 and has held it in 2 quarters since. The position peaked at $17.4K in Q1 2026. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Fifth Third Bancorp held 1,415 shares of Kura Oncology worth $15.5K as of Q2 2026.
  • Fifth Third Bancorp sold 728 Kura Oncology shares in Q2 2026, an estimated $6.87K.
  • Kura Oncology made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3620 holding.
  • Fifth Third Bancorp first reported a position in Kura Oncology in Q1 2026 and has held it in 2 quarters since.
  • Fifth Third Bancorp's Kura Oncology position peaked at $17.4K in Q1 2026.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.